{"gene":"BIK","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1995,"finding":"BIK (Bcl-2-interacting killer) was identified as a novel pro-apoptotic protein containing a BH3 domain that physically interacts with anti-apoptotic proteins BCL-2, BCL-XL, EBV-BHRF1, and adenovirus E1B-19 kDa; its death-promoting activity can be suppressed by co-expression of these anti-apoptotic proteins.","method":"Yeast two-hybrid, co-immunoprecipitation, transient transfection apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — foundational paper with multiple orthogonal methods (Y2H, co-IP, functional assays), replicated by subsequent studies","pmids":["7478623"],"is_preprint":false},{"year":1996,"finding":"BIK (Nbk) was cloned via yeast two-hybrid screen for E1B 19K interactors; it contains BH3 but not BH1/BH2, interacts with BCL-2 and E1B 19K in vitro and in vivo, co-localizes with cytoplasmic and nuclear membranes, antagonizes E1B 19K-mediated inhibition of apoptosis, and induces apoptosis independently of BAX.","method":"Yeast two-hybrid, in vitro binding assay, immunoprecipitation, co-localization, transient transfection apoptosis assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single rigorous study, consistent with founding paper","pmids":["8816500"],"is_preprint":false},{"year":1997,"finding":"The BH3 domain of BIK (residues 57–74) is the core heterodimerization domain required for interaction with BCL-2 and BCL-XL, but heterodimerization alone is insufficient for cell death; C-terminal sequences beyond residue 120 are additionally required for efficient apoptotic activity.","method":"Deletion mutagenesis, yeast two-hybrid, immunoprecipitation, functional apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with functional validation, multiple orthogonal methods","pmids":["9305912"],"is_preprint":false},{"year":1997,"finding":"BIK and BAK induce apoptosis downstream of the CrmA block but upstream of the IAP (inhibitor of apoptosis) block, placing BIK in a defined position within the caspase activation cascade.","method":"Genetic epistasis using CrmA and IAP expression constructs with apoptosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean epistasis experiment with defined pathway placement","pmids":["9082997"],"is_preprint":false},{"year":2000,"finding":"BIK is phosphorylated at Thr33 and Ser35; mutation of these residues to alanine reduces apoptotic activity without significantly affecting heterodimerization with BCL-2; partial purification suggests BIK is phosphorylated by a casein kinase II-related enzyme.","method":"Phosphorylation mapping, site-directed mutagenesis, partial kinase purification from HeLa cell extracts, functional apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with biochemical kinase identification and functional validation","pmids":["11084041"],"is_preprint":false},{"year":2002,"finding":"BIK is localized to the endoplasmic reticulum membrane (with bulk of the protein facing the cytosol) and stimulates cytochrome c release from mitochondria and caspase activation from this ER location; restricting BIK to the ER via the cytochrome b5 transmembrane anchor retains its cell death activity; this pathway was reconstituted in vitro requiring ER and cytosol components.","method":"Subcellular fractionation, chimeric membrane anchor constructs, in vitro reconstitution, caspase inhibitor treatment, functional apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus chimeric construct approach and organelle fractionation, strong mechanistic data","pmids":["11884414"],"is_preprint":false},{"year":2002,"finding":"BIK/NBK is induced at the mRNA level by oncogenic E1A in a wild-type p53-dependent manner, and by p53 independently; BIK function requires an intact BH3 domain (point mutation abrogates activity); a significant fraction of endogenous BIK associates with the endoplasmic reticulum.","method":"DNA microarray, RT-PCR, Western blot, subcellular fractionation, BH3 domain point mutagenesis, apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing ER localization and p53-dependent induction","pmids":["11971188"],"is_preprint":false},{"year":2003,"finding":"BIK (Nbk) induces apoptosis through an entirely BAX-dependent mechanism; BAX-deficient cells are resistant to BIK-induced apoptosis even when BAK is expressed; re-expression of BAX restores sensitivity; BIK interacts with BCL-XL and BCL-2 but not BAX; BIK does not localize to mitochondria, suggesting it acts as an indirect activator of BAX.","method":"Conditional adenoviral expression system (Tet-off), BAX-deficient cell lines, BAX re-expression, immunoprecipitation, subcellular localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue experiments with multiple cell line models and orthogonal methods","pmids":["12853473"],"is_preprint":false},{"year":2005,"finding":"ER-localized BIK activates a pathway involving calcium (Ca2+) release from ER stores upstream of BAX/BAK activation; this triggers DRP1 recruitment, mitochondrial fragmentation, and DRP1-dependent remodelling and opening of cristae; BIK can cooperate with NOXA to activate BAX and cause rapid cytochrome c release independently of DRP1 enzymatic activity.","method":"Live cell imaging, DRP1 dominant-negative and siRNA, selective membrane permeabilization with digitonin, cytochrome c release assays, BIK ER-restricted constructs","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including dominant-negative DRP1, siRNA, and live imaging in intact cells","pmids":["15791210"],"is_preprint":false},{"year":2005,"finding":"BIK initiates BAX/BAK-dependent Ca2+ release from ER stores upstream of effector caspases; BIK knockdown blocks ER Ca2+ release and mitochondrial apoptosis in human epithelial cells; DRP1 is required for p53-induced mitochondrial fission and cytochrome c release downstream of BIK; p53 overexpression stimulates BAK recruitment to the ER, which is inhibited by BIK siRNA.","method":"siRNA knockdown, Ca2+ release assays, BAX/BAK double-knockout BMK cells, cytochrome c release assays, immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown with multiple functional readouts and use of knockout cells","pmids":["15809295"],"is_preprint":false},{"year":2005,"finding":"BIK protein is stabilized from proteasomal degradation by bortezomib, leading to its accumulation; BIK (together with BIM) is required for bortezomib-induced apoptosis, as double knockout of Bik and Bim in MEFs renders cells resistant; BIK acts through the mitochondrial pathway (APAF-1 dependent).","method":"Proteasome inhibitor treatment, MEF double-knockout cells, RNA interference, APAF-1-deficient cells, apoptosis assays","journal":"Molecular cancer therapeutics","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with double-knockout cells and RNAi, multiple cell types tested","pmids":["15767553"],"is_preprint":false},{"year":2007,"finding":"BIK (NBK) activates BAK-mediated apoptosis in response to protein synthesis inhibition by displacing BAK from sequestration by anti-apoptotic MCL-1 and BCL-XL; BIK- or BAK-deficient cells are resistant to translation inhibition-induced apoptosis.","method":"MazF toxin-induced translation inhibition, BIK/BAK-deficient cells, immunoprecipitation to assess MCL-1/BAK and BCL-XL/BAK complexes, genetic rescue experiments","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with mechanistic dissection of BIK-MCL-1/BCL-XL-BAK pathway","pmids":["17403773"],"is_preprint":false},{"year":2007,"finding":"GRP78/BiP physically interacts with BIK at the ER; GRP78 overexpression inhibits estrogen starvation-induced BAX activation and apoptosis; GRP78 knockdown sensitizes cells to estrogen starvation-induced apoptosis in a BIK-dependent manner.","method":"Co-immunoprecipitation, GRP78 overexpression and siRNA knockdown, BAX activation assays, apoptosis assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with functional validation using siRNA, multiple apoptotic readouts","pmids":["17440086"],"is_preprint":false},{"year":2007,"finding":"MCL-1 binding to BAK persists after BIK expression and prevents BIK-induced apoptosis in BAX-deficient cells; PUMA (but not BIK) can disrupt MCL-1-BAK interaction; targeted knockdown of MCL-1 allows BAK activation by BIK, demonstrating that BIK's BAX-dependency is due to MCL-1 inhibiting BAK.","method":"Immunoprecipitation, MCL-1 siRNA knockdown, BAX-deficient cell lines, apoptosis assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection via co-IP and siRNA in isogenic cell lines","pmids":["18025305"],"is_preprint":false},{"year":2008,"finding":"RHBDD1, a rhomboid serine protease, cleaves BIK at a site in its transmembrane region; residues Gly142 and Ser144 of RHBDD1 are critical for this cleavage; RHBDD1 overexpression reduces BIK-mediated apoptosis while knockdown enhances it.","method":"Mutagenesis of RHBDD1 active site, overexpression/knockdown experiments, apoptosis assays","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional validation, single lab study","pmids":["18953687"],"is_preprint":false},{"year":2008,"finding":"BIK interacts with phospho-ERK1/2 and suppresses nuclear translocation of activated ERK1/2; this is dependent on a functional BH3 domain (BikL61G mutant does not interact or suppress nuclear pERK1/2); BIK-mediated suppression of nuclear pERK1/2 is required for IFNγ-induced cell death in airway epithelial cells.","method":"Co-immunoprecipitation, BH3 domain point mutant (L61G), nuclear/cytosolic fractionation, bik-/- mouse AECs, phospho-ERK inhibition, apoptosis assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — co-IP, loss-of-function (bik-/- cells), and mutagenesis with defined functional consequence","pmids":["18981230"],"is_preprint":false},{"year":2009,"finding":"TGF-β directly induces BIK transcription via Smad transcription factor complexes binding to a consensus Smad-binding element in the BIK promoter; TGF-β also represses BCL-XL; both effects cooperate to activate the intrinsic apoptotic pathway in B cells.","method":"Chromatin immunoprecipitation (ChIP), promoter-reporter assays, Smad-binding element identification, shRNA knockdown of BIK, BCL-XL overexpression","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirming direct Smad binding to BIK promoter, combined with functional shRNA rescue experiments","pmids":["19136942"],"is_preprint":false},{"year":2011,"finding":"GRP78 interacts with BIK independently of the BH3 domain (unlike all other BIK protein interactions); GRP78 and BCL-2 form independent complexes with BIK; increased GRP78 expression decreases BIK binding to BCL-2, releasing BCL-2 from sequestration to suppress apoptosis.","method":"Co-immunoprecipitation, BH3 domain mutants, GRP78 overexpression, isolated clonal cell lines, apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — mechanistic co-IP with domain mapping and functional validation","pmids":["21622563"],"is_preprint":false},{"year":2012,"finding":"BIK mRNA 3' end processing and expression are controlled by the poly(A) polymerase Star-PAP downstream of DNA damage; nuclear PKCδ associates with the Star-PAP complex and is required for Star-PAP-dependent BIK expression; PIPKIα binds PKCδ and is essential for PKCδ interaction with Star-PAP, with PKCδ activity stimulated by PI4,5P2.","method":"siRNA knockdown, co-immunoprecipitation, mRNA 3' end processing assays, kinase activity assays, BIK mRNA 3' UTR analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, functional siRNA, biochemical assays) establishing a nuclear signaling complex controlling BIK expression","pmids":["22244330"],"is_preprint":false},{"year":2012,"finding":"Src kinase-dependent resistance to apoptosis operates via Ras-Raf-Mek1/2-Erk1/2 pathway phosphorylation of BIK on Thr124, which drives BIK ubiquitylation on Lys33 and subsequent proteasomal degradation.","method":"v-Src transformed fibroblasts, Erk1/2 pathway inhibitors, phosphorylation site mutagenesis (Thr124), ubiquitylation assays, proteasome inhibition, apoptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of phosphorylation and ubiquitylation sites with biochemical validation of the degradation mechanism","pmids":["22388352"],"is_preprint":false},{"year":2014,"finding":"SQSTM1/p62 knockdown causes cargo loading failure in autophagy, leading to accumulation of NBK/Bik on ER membranes (by blocking autophagic loading and degradation of NBK/Bik), which triggers apoptosis; NBK/Bik knockdown markedly attenuates this apoptosis in vitro and in vivo.","method":"shRNA targeting SQSTM1/p62 and NBK/Bik, autophagy flux assays, ER membrane fractionation, xenograft tumor model, apoptosis assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway placement with genetic knockdown and in vivo validation, single lab","pmids":["25002530"],"is_preprint":false},{"year":2017,"finding":"BIK dissociates the BAK/BCL-2 complex to enrich ER-associated BAK; BIK interacts with the kinase domain of DAPk1 to form a BIK-DAPk1-ERK1/2-BAK complex; BIK disrupts BCL-2/IP3R interaction to cause ER Ca2+ release; ER-associated BAK interacts with DAPk1 to increase ER-mitochondria contact sites facilitating mitochondrial Ca2+ uptake; the BIK BH3 helix is sufficient for ER-BAK enrichment and ER Ca2+ release but not for mitochondrial Ca2+ uptake (requires Bak).","method":"Co-immunoprecipitation, BAK knockdown, IP3R interaction assays, ER-mitochondria contact site imaging, BIK BH3 peptide experiments, Ca2+ flux assays, allergen/cigarette smoke mouse models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical and cell biological methods with in vivo validation, strong mechanistic detail","pmids":["28986568"],"is_preprint":false},{"year":2017,"finding":"p53-mediated suppression of BiP expression during prolonged ER stress releases pro-apoptotic BIK from BiP, activating apoptosis; p53 suppresses bip mRNA translation by binding to the first 346-nt of bip mRNA via a p53 trans-suppression domain in the first 7 N-terminal amino acids of p53ΔN40.","method":"RNA-protein binding assays, siRNA knockdown of BiP and BIK, co-immunoprecipitation, p53 isoform expression, ER stress induction, apoptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection of mRNA-protein binding and apoptotic release with multiple functional validations","pmids":["28622297"],"is_preprint":false},{"year":2019,"finding":"The E3 ubiquitin ligase Cul5-ASB11 targets BIK for ubiquitination and degradation; ER stress activates ASB11 via the IRE1α-XBP1s axis during the adaptive UPR, stimulating BIK ubiquitination, interaction with p97/VCP, and proteolysis; genotoxic stress down-regulates this axis, stabilizing BIK to promote apoptosis.","method":"Co-immunoprecipitation, ubiquitination assays, IRE1α inhibitor, XBP1s overexpression/knockdown, ASB11 knockdown, p97/VCP interaction assays, apoptosis assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — E3 ligase identification with mechanistic pathway dissection through multiple orthogonal methods","pmids":["31387940"],"is_preprint":false},{"year":2021,"finding":"Casein kinase IIα (CKIIα) phosphorylates and activates BIK to kill cells specifically in S/G2/M phase of the cell cycle; CKIIα is expressed only during G2/M phase; BIK phosphorylation at Thr33/Ser35 is required for activity even in quiescent cells; BIK localizes to and is only detected in green-fluorescent (S/G2/M) cells as shown by fluorescent cell cycle indicators.","method":"Fluorescent ubiquitin cell cycle indicators (FUCCI), co-immunoprecipitation, proteomics, BIK phosphorylation mutants, transgenic mouse airway epithelial cells, allergen exposure model","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 — co-IP/proteomics identifying kinase, combined with FUCCI cell cycle tracking and mutagenesis","pmids":["34741311"],"is_preprint":false},{"year":2023,"finding":"BIK is detected at both ER and mitochondria-associated ER membranes (MAMs); BIK binds directly to mitochondria-localized BCL-XL and BCL-2 in a BH3-domain-dependent manner as shown by FLIM-FRET microscopy; BIK or its binding partners relocalize at ER-mitochondria contact sites to initiate mitochondrial outer membrane permeabilization.","method":"FLIM-FRET microscopy, chimeric mitochondria-localized BCL-XL/BCL-2 mutants, BAX/BAK double-knockout BMK cells, BH3-domain mutants, co-localization in MCF-7 and BMK cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct structural interaction measured by FLIM-FRET with chimeric protein controls and genetic validation","pmids":["36603764"],"is_preprint":false},{"year":2023,"finding":"BIK interacts with the BH4 domain of BCL-2 and with proteasome subunits RPN1 and RPN2 to enhance proteasomal degradation of nuclear proteins, suppressing NF-κB nuclear p65; BIK deficiency increases nuclear p65 and causes low-grade inflammation and spontaneous emphysema in female mice.","method":"Co-immunoprecipitation, proteasomal degradation assays, transgenic BIK airway expression, bik-/- mice, nuclear fractionation, NF-κB p65 quantification","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — co-IP identifying novel BCL-2/RPN1/RPN2 interaction with in vivo genetic validation in knockout mice","pmids":["38113109"],"is_preprint":false},{"year":2023,"finding":"TMEM215 forms a complex with BiP and facilitates BiP interaction with BIK; TMEM215 knockdown triggers BIK-dependent apoptosis associated with increased mitochondria-associated ER membrane contacts and mitochondrial calcium influx; blocking IP3R or MCU abrogates TMEM215 knockdown-induced apoptosis.","method":"Co-immunoprecipitation-mass spectrometry, BIK siRNA rescue, IP3R/MCU inhibitors, mitochondria-associated ER membrane imaging, EC-specific conditional knockout mice, tumor models","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — IP-MS identification of TMEM215-BiP-BIK complex with in vivo genetic validation and mechanistic calcium pathway dissection","pmids":["37750320"],"is_preprint":false},{"year":2016,"finding":"BIK promotes caspase-dependent cleavage of influenza A virus nucleoprotein and M2 proteins, facilitating cytoplasmic export of viral ribonucleoprotein; bik-/- mouse airway epithelial cells show reduced viral titers, caspase 3 activation, and viral RNA export compared to wild-type cells.","method":"bik-/- mouse airway epithelial cells, caspase inhibition, viral protein cleavage assays, viral RNP export assays, in vivo infection model","journal":"American journal of respiratory cell and molecular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with multiple mechanistic readouts (caspase activation, viral protein cleavage, RNP export) in vitro and in vivo","pmids":["26437021"],"is_preprint":false},{"year":2014,"finding":"HCV NS5B RNA-dependent RNA polymerase induces BIK expression; BIK co-localizes and co-immunoprecipitates with NS5B, suggesting BIK interacts with the HCV replication complex; BIK depletion significantly suppresses viral RNA replication and release.","method":"PCR array, co-immunoprecipitation, immunofluorescence co-localization, BIK siRNA knockdown, viral replication assays","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP/co-localization with functional siRNA validation, single lab","pmids":["25463603"],"is_preprint":false},{"year":2017,"finding":"TMEM74, a lysosome transmembrane protein, co-localizes with BIK in subcellular organelles and associates with BIK via the TM domains of TMEM74 and the BH3 domain of BIK; TMEM74 inhibits BIK-induced apoptosis through this direct interaction.","method":"Co-immunoprecipitation, fluorescent co-localization, domain mapping with TM-deficient mutants, BIK apoptosis assays with TMEM74 knockdown/overexpression","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP with domain mapping and functional rescue, single lab","pmids":["28412412"],"is_preprint":false},{"year":2005,"finding":"Concomitant loss of both Bik and Bim (but not either alone) arrests spermatogenesis in mice, resulting in infertility and testicular cellularity reduction similar to Bax deficiency; Bik and Bim act upstream of Bax to eliminate supernumerary germ cells during the first wave of spermatogenesis.","method":"Bik/Bim double-knockout mice, histological and cell count analyses, genetic epistasis with Bax-deficient mice","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean double-knockout genetic epistasis with defined in vivo phenotype and pathway placement upstream of Bax","pmids":["16270031"],"is_preprint":false}],"current_model":"BIK is a BH3-only pro-apoptotic protein constitutively localized to the endoplasmic reticulum (ER) membrane via its C-terminal transmembrane domain, where it initiates mitochondrial apoptosis by: (1) binding and neutralizing anti-apoptotic BCL-2, BCL-XL, and MCL-1 via its BH3 domain; (2) disrupting BCL-2/IP3R interactions to release ER Ca2+ stores, which—together with DAPk1 and ER-enriched BAK—facilitates mitochondrial Ca2+ uptake at MAM contact sites; (3) promoting DRP1-dependent mitochondrial cristae remodeling; and (4) cooperating with BAK/BAX to release cytochrome c; its pro-apoptotic activity is activated by casein kinase II-mediated phosphorylation at Thr33/Ser35, is suppressed by ERK1/2-dependent phosphorylation of Thr124 driving Cul5-ASB11/ubiquitin-proteasomal degradation, and is regulated at the mRNA level by p53, E2F, Smad, and nuclear PI4,5P2/PKCδ/Star-PAP signaling; additionally, BIK interacts with proteasome subunits RPN1/RPN2 via the BCL-2 BH4 domain to enhance proteasomal degradation of nuclear proteins (including NF-κB p65), revealing a non-apoptotic function in suppressing inflammation."},"narrative":{"teleology":[{"year":1995,"claim":"Identification of BIK as a BH3-domain-containing pro-apoptotic protein that physically engages anti-apoptotic BCL-2 family members established it as a death-promoting antagonist of survival proteins.","evidence":"Yeast two-hybrid, co-immunoprecipitation, and apoptosis assays in transfected cells","pmids":["7478623","8816500"],"confidence":"High","gaps":["Mechanism of death induction beyond heterodimerization was unknown","Subcellular site of action unresolved","Endogenous regulation of BIK expression and turnover not addressed"]},{"year":1997,"claim":"Mapping the BH3 domain as necessary for BCL-2/BCL-XL binding but insufficient for apoptosis revealed that a C-terminal region (beyond residue 120) provides an additional required function, later shown to be the ER-targeting transmembrane anchor.","evidence":"Deletion mutagenesis with yeast two-hybrid and functional apoptosis assays","pmids":["9305912","9082997"],"confidence":"High","gaps":["Nature of the C-terminal contribution (membrane anchor vs. protein interaction) was unresolved","Downstream effectors were not identified"]},{"year":2000,"claim":"Discovery that phosphorylation at Thr33/Ser35 by a casein kinase II-related enzyme activates BIK's pro-apoptotic function established the first post-translational activation mechanism for BIK.","evidence":"Phosphorylation mapping, site-directed mutagenesis, partial kinase purification from HeLa extracts","pmids":["11084041"],"confidence":"High","gaps":["Identity of the kinase was only partial (CKII-related)","Cell-cycle context of phosphorylation was unknown","Relationship between phosphorylation and BCL-2 binding was unclear"]},{"year":2002,"claim":"Localization of BIK to the ER membrane—with retention of full apoptotic activity when ER-restricted—fundamentally redefined BIK as an ER-resident initiator of mitochondrial apoptosis, distinct from mitochondria-localized BH3-only proteins.","evidence":"Subcellular fractionation, chimeric ER-anchor constructs, in vitro reconstitution with ER and cytosol, p53-induction studies","pmids":["11884414","11971188"],"confidence":"High","gaps":["Signal transmitted from ER to mitochondria was unidentified","Whether Ca²⁺ was involved was unknown"]},{"year":2003,"claim":"Demonstration that BIK-induced apoptosis is entirely BAX-dependent—even in BAK-expressing cells—positioned BIK as an indirect activator that de-represses effector proteins rather than directly permeabilizing membranes.","evidence":"Conditional adenoviral BIK expression in BAX-deficient cells with BAX re-expression rescue","pmids":["12853473"],"confidence":"High","gaps":["How BIK signals to BAX from the ER was mechanistically undefined","Role of BAK at the ER was not yet explored"]},{"year":2005,"claim":"Multiple studies converged to show that ER-localized BIK triggers Ca²⁺ release from ER stores, recruits DRP1 for mitochondrial cristae remodeling, and cooperates with BAX/BAK for cytochrome c release—establishing the ER-to-mitochondria Ca²⁺ signaling axis as the core BIK mechanism; in parallel, Bik/Bim double-knockout mice revealed a physiological role in spermatogenesis upstream of Bax.","evidence":"Live imaging, DRP1 dominant-negative/siRNA, Ca²⁺ assays, BAX/BAK DKO cells, Bik/Bim DKO mice with histology","pmids":["15791210","15809295","15767553","16270031"],"confidence":"High","gaps":["Identity of the ER Ca²⁺ channel involved was not determined","Precise mechanism of DRP1 recruitment was unclear","Whether BIK directly engages BAK at the ER was unknown"]},{"year":2007,"claim":"BIK was shown to displace BAK from MCL-1/BCL-XL sequestration, while GRP78/BiP was identified as an ER-resident inhibitor that sequesters BIK independently of the BH3 domain—revealing dual layers of BIK regulation at the ER.","evidence":"Co-immunoprecipitation of MCL-1/BAK complexes after BIK expression; GRP78 overexpression/siRNA with apoptosis readouts; BH3-mutant mapping","pmids":["17403773","17440086","18025305"],"confidence":"High","gaps":["BIK's inability to displace MCL-1 from BAK (unlike PUMA) left the MCL-1 neutralization mechanism incomplete","GRP78 binding site on BIK was unmapped"]},{"year":2008,"claim":"BIK was found to interact with phospho-ERK1/2 via its BH3 domain and suppress ERK nuclear translocation, revealing a non-canonical signaling function; separately, RHBDD1 rhomboid protease was identified as cleaving BIK in its transmembrane domain to attenuate apoptosis.","evidence":"Co-IP with BH3 mutant control and bik−/− cells for ERK; RHBDD1 active-site mutagenesis with apoptosis assays","pmids":["18981230","18953687"],"confidence":"High","gaps":["Physiological contexts for RHBDD1-mediated BIK cleavage were not defined","Whether ERK sequestration and apoptosis induction are separable functions was unclear"]},{"year":2009,"claim":"Identification of direct Smad-binding elements in the BIK promoter established TGF-β as a transcriptional inducer of BIK, adding to the p53/E2F axis and explaining BIK's role in TGF-β-induced B-cell apoptosis.","evidence":"ChIP showing Smad binding to BIK promoter, promoter-reporter assays, BIK shRNA rescue","pmids":["19136942"],"confidence":"High","gaps":["Whether other Smad family members differentially regulate BIK was not tested","Integration of multiple transcriptional inputs was not modeled"]},{"year":2012,"claim":"Two degradation-regulation mechanisms were defined: ERK1/2-mediated Thr124 phosphorylation drives Lys33 ubiquitylation and proteasomal degradation of BIK (explaining Src/Ras oncogene resistance), while Star-PAP/PKCδ/PI4,5P2 nuclear signaling controls BIK mRNA 3′ end processing after DNA damage.","evidence":"Phosphosite mutagenesis with ubiquitylation assays in v-Src-transformed cells; siRNA/co-IP of Star-PAP complex with mRNA processing assays","pmids":["22388352","22244330"],"confidence":"High","gaps":["The E3 ligase mediating Thr124-dependent ubiquitylation was not identified in this study","Whether Star-PAP regulation extends to other BH3-only genes was unknown"]},{"year":2017,"claim":"BIK was shown to form a complex with DAPk1, ERK1/2, and BAK at the ER, disrupt BCL-2/IP3R interactions to release ER Ca²⁺, and increase ER–mitochondria contact sites for mitochondrial Ca²⁺ uptake—providing a complete mechanistic pathway from ER perturbation to mitochondrial engagement.","evidence":"Co-IP, IP3R interaction assays, ER–mitochondria contact imaging, BH3 peptide experiments, Ca²⁺ flux measurements, in vivo allergen/smoke models","pmids":["28986568"],"confidence":"High","gaps":["Structural basis of BIK–DAPk1 interaction was not resolved","Stoichiometry and dynamics of the quaternary complex were undefined"]},{"year":2019,"claim":"Identification of Cul5-ASB11 as the E3 ligase targeting BIK, activated by the IRE1α-XBP1s adaptive UPR and involving p97/VCP extraction, explained how ER stress initially suppresses BIK to allow adaptation, while genotoxic stress downregulates this axis to stabilize BIK.","evidence":"Co-IP, ubiquitination assays, IRE1α inhibitor, XBP1s and ASB11 knockdown, p97/VCP interaction assays","pmids":["31387940"],"confidence":"High","gaps":["Whether Cul5-ASB11 also mediates the ERK-Thr124-dependent degradation was not tested","Recognition determinants on BIK for ASB11 binding were unmapped"]},{"year":2021,"claim":"CKIIα was confirmed as the activating kinase for BIK, and its expression restricted to G2/M phase explained why BIK kills specifically dividing (S/G2/M) cells—linking BIK activation to cell-cycle progression.","evidence":"FUCCI cell-cycle tracking, co-IP/proteomics identifying CKIIα, phosphomutant BIK in transgenic mouse airway epithelial cells","pmids":["34741311"],"confidence":"High","gaps":["Whether CKIIα phosphorylation creates a binding interface for downstream effectors was unknown","Cell-type generality beyond airway epithelia was not established"]},{"year":2023,"claim":"Three major advances: FLIM-FRET confirmed direct BIK interaction with mitochondria-localized BCL-XL/BCL-2 at MAMs; TMEM215-BiP was identified as a ternary complex restraining BIK; and BIK's interaction with RPN1/RPN2 proteasome subunits via BCL-2 BH4 domain was shown to promote nuclear proteasomal degradation of NF-κB p65, revealing a non-apoptotic anti-inflammatory function (Bik−/− female mice develop spontaneous emphysema).","evidence":"FLIM-FRET with chimeric constructs; IP-MS for TMEM215-BiP-BIK; co-IP/proteasome assays and bik−/− mice with lung pathology","pmids":["36603764","37750320","38113109"],"confidence":"High","gaps":["Structural basis for BIK–RPN1/RPN2 interaction is unresolved","Sex-specific mechanism of emphysema in Bik−/− mice is unexplained","Whether BIK's proteasomal function operates in tissues beyond lung is unknown"]},{"year":null,"claim":"Key open questions include the structural basis of BIK's multivalent interactions at ER–mitochondria contact sites, how its apoptotic and non-apoptotic (proteasomal/anti-inflammatory) functions are partitioned in different cell types, and whether BIK loss contributes to human disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of BIK in complex with any partner","Human genetic disease associations via causative mutations are absent","Relative contributions of CKIIα activation vs. Cul5-ASB11 degradation in setting BIK protein levels in vivo are unquantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,7,11,13,15,26]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,6,20,21,25,27]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,5,7,8,9,10,11,13,21,25]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[22,23]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[15,16,19]}],"complexes":[],"partners":["BCL2","BCL2L1","MCL1","BAK1","HSPA5","DAPK1","PSMD1","ASB11"],"other_free_text":[]},"mechanistic_narrative":"BIK is a BH3-only pro-apoptotic member of the BCL-2 family that functions as a sentinel at the endoplasmic reticulum to initiate the intrinsic mitochondrial apoptotic pathway. Anchored to the ER membrane via its C-terminal transmembrane domain with its bulk facing the cytosol, BIK uses its BH3 domain to bind and neutralize anti-apoptotic BCL-2, BCL-XL, and MCL-1, thereby liberating BAK and enabling BAX activation; it also disrupts BCL-2/IP3R complexes to trigger ER Ca²⁺ release, promotes DRP1-dependent mitochondrial cristae remodeling, and facilitates mitochondrial Ca²⁺ uptake at ER–mitochondria contact sites through a DAPk1-dependent mechanism [PMID:7478623, PMID:11884414, PMID:15791210, PMID:28986568, PMID:36603764]. BIK is activated by casein kinase IIα phosphorylation at Thr33/Ser35 during S/G2/M phase, transcriptionally induced by p53, Smad, and Star-PAP/PKCδ signaling, sequestered by ER chaperone GRP78/BiP, and targeted for proteasomal degradation via ERK1/2-mediated Thr124 phosphorylation and the Cul5-ASB11 E3 ligase under the IRE1α-XBP1s adaptive UPR [PMID:11084041, PMID:34741311, PMID:22388352, PMID:31387940, PMID:17440086, PMID:19136942]. Beyond apoptosis, BIK interacts with proteasome subunits RPN1/RPN2 via the BCL-2 BH4 domain to enhance nuclear proteasomal degradation of NF-κB p65, suppressing inflammation; accordingly, Bik-deficient female mice develop spontaneous emphysema with low-grade inflammation [PMID:38113109]."},"prefetch_data":{"uniprot":{"accession":"Q13323","full_name":"Bcl-2-interacting killer","aliases":["Apoptosis inducer NBK","BIP1","BP4"],"length_aa":160,"mass_kda":18.0,"function":"Accelerates programmed cell death. Association to the apoptosis repressors Bcl-X(L), BHRF1, Bcl-2 or its adenovirus homolog E1B 19k protein suppresses this death-promoting activity. Does not interact with BAX","subcellular_location":"Endomembrane system; Mitochondrion membrane","url":"https://www.uniprot.org/uniprotkb/Q13323/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BIK","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BIK","total_profiled":1310},"omim":[{"mim_id":"621029","title":"RING FINGER PROTEIN 183; RNF183","url":"https://www.omim.org/entry/621029"},{"mim_id":"619478","title":"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 4, DIGENIC; FSHD4","url":"https://www.omim.org/entry/619478"},{"mim_id":"614350","title":"LYNCH SYNDROME 5; LYNCH5","url":"https://www.omim.org/entry/614350"},{"mim_id":"606266","title":"BCL2-MODIFYING FACTOR; BMF","url":"https://www.omim.org/entry/606266"},{"mim_id":"606009","title":"DOUBLE HOMEOBOX PROTEIN 4; DUX4","url":"https://www.omim.org/entry/606009"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":16.9}],"url":"https://www.proteinatlas.org/search/BIK"},"hgnc":{"alias_symbol":["NBK"],"prev_symbol":[]},"alphafold":{"accession":"Q13323","domains":[{"cath_id":"1.20.5","chopping":"52-87","consensus_level":"medium","plddt":70.4175,"start":52,"end":87},{"cath_id":"1.10.287","chopping":"90-158","consensus_level":"high","plddt":72.3328,"start":90,"end":158}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13323","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13323-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13323-F1-predicted_aligned_error_v6.png","plddt_mean":62.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BIK","jax_strain_url":"https://www.jax.org/strain/search?query=BIK"},"sequence":{"accession":"Q13323","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13323.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13323/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13323"}},"corpus_meta":[{"pmid":"7478623","id":"PMC_7478623","title":"Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7478623","citation_count":408,"is_preprint":false},{"pmid":"15791210","id":"PMC_15791210","title":"Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15791210","citation_count":284,"is_preprint":false},{"pmid":"17440086","id":"PMC_17440086","title":"GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17440086","citation_count":264,"is_preprint":false},{"pmid":"8816500","id":"PMC_8816500","title":"Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8816500","citation_count":168,"is_preprint":false},{"pmid":"15767553","id":"PMC_15767553","title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.","date":"2005","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15767553","citation_count":150,"is_preprint":false},{"pmid":"15809295","id":"PMC_15809295","title":"BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15809295","citation_count":149,"is_preprint":false},{"pmid":"27845892","id":"PMC_27845892","title":"LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27845892","citation_count":124,"is_preprint":false},{"pmid":"11884414","id":"PMC_11884414","title":"BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11884414","citation_count":123,"is_preprint":false},{"pmid":"21622563","id":"PMC_21622563","title":"Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21622563","citation_count":112,"is_preprint":false},{"pmid":"17403773","id":"PMC_17403773","title":"NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17403773","citation_count":112,"is_preprint":false},{"pmid":"15824729","id":"PMC_15824729","title":"Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15824729","citation_count":109,"is_preprint":false},{"pmid":"11971188","id":"PMC_11971188","title":"Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11971188","citation_count":107,"is_preprint":false},{"pmid":"12853473","id":"PMC_12853473","title":"Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12853473","citation_count":107,"is_preprint":false},{"pmid":"19641504","id":"PMC_19641504","title":"BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19641504","citation_count":103,"is_preprint":false},{"pmid":"14749373","id":"PMC_14749373","title":"Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14749373","citation_count":99,"is_preprint":false},{"pmid":"16270031","id":"PMC_16270031","title":"Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16270031","citation_count":85,"is_preprint":false},{"pmid":"16322756","id":"PMC_16322756","title":"Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16322756","citation_count":85,"is_preprint":false},{"pmid":"19136942","id":"PMC_19136942","title":"TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19136942","citation_count":77,"is_preprint":false},{"pmid":"11084041","id":"PMC_11084041","title":"Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11084041","citation_count":74,"is_preprint":false},{"pmid":"14983013","id":"PMC_14983013","title":"The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14983013","citation_count":72,"is_preprint":false},{"pmid":"22244330","id":"PMC_22244330","title":"Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22244330","citation_count":68,"is_preprint":false},{"pmid":"25002530","id":"PMC_25002530","title":"Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25002530","citation_count":67,"is_preprint":false},{"pmid":"11782349","id":"PMC_11782349","title":"Systemic tumor suppression by the proapoptotic gene bik.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11782349","citation_count":65,"is_preprint":false},{"pmid":"18566236","id":"PMC_18566236","title":"Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.","date":"2008","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/18566236","citation_count":62,"is_preprint":false},{"pmid":"17873911","id":"PMC_17873911","title":"BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17873911","citation_count":57,"is_preprint":false},{"pmid":"9305912","id":"PMC_9305912","title":"Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9305912","citation_count":54,"is_preprint":false},{"pmid":"16082182","id":"PMC_16082182","title":"Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.","date":"2005","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16082182","citation_count":53,"is_preprint":false},{"pmid":"9082997","id":"PMC_9082997","title":"Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9082997","citation_count":51,"is_preprint":false},{"pmid":"11803466","id":"PMC_11803466","title":"The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11803466","citation_count":50,"is_preprint":false},{"pmid":"18953687","id":"PMC_18953687","title":"A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.","date":"2008","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/18953687","citation_count":49,"is_preprint":false},{"pmid":"22388352","id":"PMC_22388352","title":"Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22388352","citation_count":49,"is_preprint":false},{"pmid":"28622297","id":"PMC_28622297","title":"p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28622297","citation_count":48,"is_preprint":false},{"pmid":"30176890","id":"PMC_30176890","title":"KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.","date":"2018","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/30176890","citation_count":48,"is_preprint":false},{"pmid":"17047080","id":"PMC_17047080","title":"Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17047080","citation_count":48,"is_preprint":false},{"pmid":"18981230","id":"PMC_18981230","title":"The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18981230","citation_count":46,"is_preprint":false},{"pmid":"14633680","id":"PMC_14633680","title":"Enhancement of Bik antitumor effect by Bik mutants.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14633680","citation_count":45,"is_preprint":false},{"pmid":"12874789","id":"PMC_12874789","title":"Mutations of the BIK gene in human peripheral B-cell lymphomas.","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12874789","citation_count":44,"is_preprint":false},{"pmid":"21317312","id":"PMC_21317312","title":"Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia.","date":"2011","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21317312","citation_count":44,"is_preprint":false},{"pmid":"18025305","id":"PMC_18025305","title":"Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18025305","citation_count":43,"is_preprint":false},{"pmid":"10419903","id":"PMC_10419903","title":"Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10419903","citation_count":43,"is_preprint":false},{"pmid":"11342619","id":"PMC_11342619","title":"Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11342619","citation_count":41,"is_preprint":false},{"pmid":"19219069","id":"PMC_19219069","title":"PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19219069","citation_count":37,"is_preprint":false},{"pmid":"16007125","id":"PMC_16007125","title":"Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16007125","citation_count":34,"is_preprint":false},{"pmid":"12467227","id":"PMC_12467227","title":"The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain.","date":"2001","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/12467227","citation_count":33,"is_preprint":false},{"pmid":"17027756","id":"PMC_17027756","title":"Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17027756","citation_count":32,"is_preprint":false},{"pmid":"31703394","id":"PMC_31703394","title":"HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31703394","citation_count":32,"is_preprint":false},{"pmid":"28287102","id":"PMC_28287102","title":"Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28287102","citation_count":29,"is_preprint":false},{"pmid":"27262843","id":"PMC_27262843","title":"Osteopontin-stimulated apoptosis in cardiac myocytes involves oxidative stress and mitochondrial death pathway: role of a pro-apoptotic protein BIK.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27262843","citation_count":28,"is_preprint":false},{"pmid":"21063407","id":"PMC_21063407","title":"BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.","date":"2010","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21063407","citation_count":26,"is_preprint":false},{"pmid":"11303912","id":"PMC_11303912","title":"GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.","date":"2000","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/11303912","citation_count":26,"is_preprint":false},{"pmid":"28986568","id":"PMC_28986568","title":"Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28986568","citation_count":25,"is_preprint":false},{"pmid":"31460837","id":"PMC_31460837","title":"Upregulation of miR-1306-5p decreases cerebral ischemia/reperfusion injury in vitro by targeting BIK.","date":"2019","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31460837","citation_count":25,"is_preprint":false},{"pmid":"37750320","id":"PMC_37750320","title":"TMEM215 Prevents Endothelial Cell Apoptosis in Vessel Regression by Blunting BIK-Regulated ER-to-Mitochondrial Ca Influx.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37750320","citation_count":24,"is_preprint":false},{"pmid":"25548100","id":"PMC_25548100","title":"Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.","date":"2014","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/25548100","citation_count":24,"is_preprint":false},{"pmid":"10974546","id":"PMC_10974546","title":"Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10974546","citation_count":23,"is_preprint":false},{"pmid":"31387940","id":"PMC_31387940","title":"BIK ubiquitination by the E3 ligase Cul5-ASB11 determines cell fate during cellular stress.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31387940","citation_count":21,"is_preprint":false},{"pmid":"28796811","id":"PMC_28796811","title":"Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28796811","citation_count":20,"is_preprint":false},{"pmid":"24554662","id":"PMC_24554662","title":"Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/24554662","citation_count":19,"is_preprint":false},{"pmid":"15953675","id":"PMC_15953675","title":"Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15953675","citation_count":19,"is_preprint":false},{"pmid":"25767602","id":"PMC_25767602","title":"Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells.","date":"2015","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25767602","citation_count":17,"is_preprint":false},{"pmid":"22513214","id":"PMC_22513214","title":"The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.","date":"2012","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22513214","citation_count":16,"is_preprint":false},{"pmid":"28412412","id":"PMC_28412412","title":"Autophagy regulatory molecule, TMEM74, interacts with BIK and inhibits BIK-induced apoptosis.","date":"2017","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/28412412","citation_count":15,"is_preprint":false},{"pmid":"30584337","id":"PMC_30584337","title":"MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30584337","citation_count":15,"is_preprint":false},{"pmid":"23991648","id":"PMC_23991648","title":"BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model.","date":"2013","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/23991648","citation_count":15,"is_preprint":false},{"pmid":"28720543","id":"PMC_28720543","title":"BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28720543","citation_count":14,"is_preprint":false},{"pmid":"24100375","id":"PMC_24100375","title":"Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.","date":"2013","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24100375","citation_count":14,"is_preprint":false},{"pmid":"29033852","id":"PMC_29033852","title":"Activation of Casein Kinase II by Gallic Acid Induces BIK-BAX/BAK-Mediated ER Ca++-ROS-Dependent Apoptosis of Human Oral Cancer Cells.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29033852","citation_count":14,"is_preprint":false},{"pmid":"17064661","id":"PMC_17064661","title":"5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17064661","citation_count":13,"is_preprint":false},{"pmid":"28784260","id":"PMC_28784260","title":"Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.","date":"2017","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28784260","citation_count":13,"is_preprint":false},{"pmid":"34517787","id":"PMC_34517787","title":"Long non-coding RNA TUG1 knockdown prevents neurons from death to alleviate acute spinal cord injury via the microRNA-338/BIK axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34517787","citation_count":11,"is_preprint":false},{"pmid":"16514421","id":"PMC_16514421","title":"Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.","date":"2006","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16514421","citation_count":11,"is_preprint":false},{"pmid":"18299962","id":"PMC_18299962","title":"The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores.","date":"2008","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18299962","citation_count":11,"is_preprint":false},{"pmid":"26437021","id":"PMC_26437021","title":"Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.","date":"2016","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26437021","citation_count":11,"is_preprint":false},{"pmid":"22573037","id":"PMC_22573037","title":"Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22573037","citation_count":10,"is_preprint":false},{"pmid":"26059411","id":"PMC_26059411","title":"Bik subcellular localization in response to oxidative stress induced by chemotherapy, in Two different breast cancer cell lines and a Non-tumorigenic epithelial cell line.","date":"2015","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/26059411","citation_count":10,"is_preprint":false},{"pmid":"30133309","id":"PMC_30133309","title":"Biodistribution and Internal Radiation Dosimetry of 99mTc-IDA-D-[c(RGDfK)]2 (BIK-505), a Novel SPECT Radiotracer for the Imaging of Integrin αvβ3 Expression.","date":"2018","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/30133309","citation_count":9,"is_preprint":false},{"pmid":"38113109","id":"PMC_38113109","title":"Bik promotes proteasomal degradation to control low-grade inflammation.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38113109","citation_count":9,"is_preprint":false},{"pmid":"17636408","id":"PMC_17636408","title":"Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer.","date":"2007","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/17636408","citation_count":9,"is_preprint":false},{"pmid":"17574210","id":"PMC_17574210","title":"Apoptosis induced by BIK was decreased with RNA interference of caspase-12.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17574210","citation_count":9,"is_preprint":false},{"pmid":"36603764","id":"PMC_36603764","title":"Endoplasmic reticulum protein BIK binds to and inhibits mitochondria-localized antiapoptotic proteins.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36603764","citation_count":8,"is_preprint":false},{"pmid":"25165875","id":"PMC_25165875","title":"Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25165875","citation_count":8,"is_preprint":false},{"pmid":"22873408","id":"PMC_22873408","title":"BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22873408","citation_count":7,"is_preprint":false},{"pmid":"26662110","id":"PMC_26662110","title":"Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26662110","citation_count":7,"is_preprint":false},{"pmid":"25463603","id":"PMC_25463603","title":"NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/25463603","citation_count":7,"is_preprint":false},{"pmid":"19898928","id":"PMC_19898928","title":"BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.","date":"2009","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19898928","citation_count":6,"is_preprint":false},{"pmid":"24637719","id":"PMC_24637719","title":"BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24637719","citation_count":6,"is_preprint":false},{"pmid":"37095508","id":"PMC_37095508","title":"Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice.","date":"2023","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/37095508","citation_count":5,"is_preprint":false},{"pmid":"38701194","id":"PMC_38701194","title":"MyoD1 promotes the transcription of BIK and plays an apoptosis-promoting role in the development of gastric cancer.","date":"2024","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/38701194","citation_count":5,"is_preprint":false},{"pmid":"35371316","id":"PMC_35371316","title":"Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer.","date":"2022","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35371316","citation_count":5,"is_preprint":false},{"pmid":"25861752","id":"PMC_25861752","title":"Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25861752","citation_count":5,"is_preprint":false},{"pmid":"26423071","id":"PMC_26423071","title":"Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.","date":"2016","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/26423071","citation_count":4,"is_preprint":false},{"pmid":"24527759","id":"PMC_24527759","title":"The increase in BIK expression following ERK1/2 pathway inhibition is a consequence of G₁ cell-cycle arrest and not a direct effect on BIK protein stability.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24527759","citation_count":4,"is_preprint":false},{"pmid":"34741311","id":"PMC_34741311","title":"Casein kinase II activates Bik to induce death of hyperplastic mucous cells in a cell cycle-dependent manner.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34741311","citation_count":3,"is_preprint":false},{"pmid":"30250907","id":"PMC_30250907","title":"Does the BCL-2 family member BIK control lung carcinogenesis?","date":"2018","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30250907","citation_count":3,"is_preprint":false},{"pmid":"34455510","id":"PMC_34455510","title":"Expression of bik cluster and production of bikaverin by Fusarium oxysporum f. sp. lycopersici grown using two alternate nitrogen sources.","date":"2021","source":"International microbiology : the official journal of the Spanish Society for Microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34455510","citation_count":2,"is_preprint":false},{"pmid":"40627391","id":"PMC_40627391","title":"BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40627391","citation_count":2,"is_preprint":false},{"pmid":"34962825","id":"PMC_34962825","title":"Rhomboid domain containing 1 promotes the growth of non-small cell lung cancer through the activation of EGFR and regulation of the BIK-mediated apoptosis.","date":"2021","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/34962825","citation_count":2,"is_preprint":false},{"pmid":"40825105","id":"PMC_40825105","title":"Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.","date":"2025","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/40825105","citation_count":1,"is_preprint":false},{"pmid":"38357926","id":"PMC_38357926","title":"Reduced Bik expression drives low-grade airway inflammation and increased risk for COPD in females.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38357926","citation_count":1,"is_preprint":false},{"pmid":"19632297","id":"PMC_19632297","title":"No association between the Bcl2-interacting killer (BIK) gene and schizophrenia.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19632297","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49467,"output_tokens":7887,"usd":0.133353},"stage2":{"model":"claude-opus-4-6","input_tokens":11665,"output_tokens":4046,"usd":0.239212},"total_usd":0.372565,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"BIK (Bcl-2-interacting killer) was identified as a novel pro-apoptotic protein containing a BH3 domain that physically interacts with anti-apoptotic proteins BCL-2, BCL-XL, EBV-BHRF1, and adenovirus E1B-19 kDa; its death-promoting activity can be suppressed by co-expression of these anti-apoptotic proteins.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, transient transfection apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational paper with multiple orthogonal methods (Y2H, co-IP, functional assays), replicated by subsequent studies\",\n      \"pmids\": [\"7478623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"BIK (Nbk) was cloned via yeast two-hybrid screen for E1B 19K interactors; it contains BH3 but not BH1/BH2, interacts with BCL-2 and E1B 19K in vitro and in vivo, co-localizes with cytoplasmic and nuclear membranes, antagonizes E1B 19K-mediated inhibition of apoptosis, and induces apoptosis independently of BAX.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding assay, immunoprecipitation, co-localization, transient transfection apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single rigorous study, consistent with founding paper\",\n      \"pmids\": [\"8816500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The BH3 domain of BIK (residues 57–74) is the core heterodimerization domain required for interaction with BCL-2 and BCL-XL, but heterodimerization alone is insufficient for cell death; C-terminal sequences beyond residue 120 are additionally required for efficient apoptotic activity.\",\n      \"method\": \"Deletion mutagenesis, yeast two-hybrid, immunoprecipitation, functional apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with functional validation, multiple orthogonal methods\",\n      \"pmids\": [\"9305912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"BIK and BAK induce apoptosis downstream of the CrmA block but upstream of the IAP (inhibitor of apoptosis) block, placing BIK in a defined position within the caspase activation cascade.\",\n      \"method\": \"Genetic epistasis using CrmA and IAP expression constructs with apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean epistasis experiment with defined pathway placement\",\n      \"pmids\": [\"9082997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BIK is phosphorylated at Thr33 and Ser35; mutation of these residues to alanine reduces apoptotic activity without significantly affecting heterodimerization with BCL-2; partial purification suggests BIK is phosphorylated by a casein kinase II-related enzyme.\",\n      \"method\": \"Phosphorylation mapping, site-directed mutagenesis, partial kinase purification from HeLa cell extracts, functional apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with biochemical kinase identification and functional validation\",\n      \"pmids\": [\"11084041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BIK is localized to the endoplasmic reticulum membrane (with bulk of the protein facing the cytosol) and stimulates cytochrome c release from mitochondria and caspase activation from this ER location; restricting BIK to the ER via the cytochrome b5 transmembrane anchor retains its cell death activity; this pathway was reconstituted in vitro requiring ER and cytosol components.\",\n      \"method\": \"Subcellular fractionation, chimeric membrane anchor constructs, in vitro reconstitution, caspase inhibitor treatment, functional apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus chimeric construct approach and organelle fractionation, strong mechanistic data\",\n      \"pmids\": [\"11884414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BIK/NBK is induced at the mRNA level by oncogenic E1A in a wild-type p53-dependent manner, and by p53 independently; BIK function requires an intact BH3 domain (point mutation abrogates activity); a significant fraction of endogenous BIK associates with the endoplasmic reticulum.\",\n      \"method\": \"DNA microarray, RT-PCR, Western blot, subcellular fractionation, BH3 domain point mutagenesis, apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing ER localization and p53-dependent induction\",\n      \"pmids\": [\"11971188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BIK (Nbk) induces apoptosis through an entirely BAX-dependent mechanism; BAX-deficient cells are resistant to BIK-induced apoptosis even when BAK is expressed; re-expression of BAX restores sensitivity; BIK interacts with BCL-XL and BCL-2 but not BAX; BIK does not localize to mitochondria, suggesting it acts as an indirect activator of BAX.\",\n      \"method\": \"Conditional adenoviral expression system (Tet-off), BAX-deficient cell lines, BAX re-expression, immunoprecipitation, subcellular localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiments with multiple cell line models and orthogonal methods\",\n      \"pmids\": [\"12853473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ER-localized BIK activates a pathway involving calcium (Ca2+) release from ER stores upstream of BAX/BAK activation; this triggers DRP1 recruitment, mitochondrial fragmentation, and DRP1-dependent remodelling and opening of cristae; BIK can cooperate with NOXA to activate BAX and cause rapid cytochrome c release independently of DRP1 enzymatic activity.\",\n      \"method\": \"Live cell imaging, DRP1 dominant-negative and siRNA, selective membrane permeabilization with digitonin, cytochrome c release assays, BIK ER-restricted constructs\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including dominant-negative DRP1, siRNA, and live imaging in intact cells\",\n      \"pmids\": [\"15791210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BIK initiates BAX/BAK-dependent Ca2+ release from ER stores upstream of effector caspases; BIK knockdown blocks ER Ca2+ release and mitochondrial apoptosis in human epithelial cells; DRP1 is required for p53-induced mitochondrial fission and cytochrome c release downstream of BIK; p53 overexpression stimulates BAK recruitment to the ER, which is inhibited by BIK siRNA.\",\n      \"method\": \"siRNA knockdown, Ca2+ release assays, BAX/BAK double-knockout BMK cells, cytochrome c release assays, immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with multiple functional readouts and use of knockout cells\",\n      \"pmids\": [\"15809295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BIK protein is stabilized from proteasomal degradation by bortezomib, leading to its accumulation; BIK (together with BIM) is required for bortezomib-induced apoptosis, as double knockout of Bik and Bim in MEFs renders cells resistant; BIK acts through the mitochondrial pathway (APAF-1 dependent).\",\n      \"method\": \"Proteasome inhibitor treatment, MEF double-knockout cells, RNA interference, APAF-1-deficient cells, apoptosis assays\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with double-knockout cells and RNAi, multiple cell types tested\",\n      \"pmids\": [\"15767553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BIK (NBK) activates BAK-mediated apoptosis in response to protein synthesis inhibition by displacing BAK from sequestration by anti-apoptotic MCL-1 and BCL-XL; BIK- or BAK-deficient cells are resistant to translation inhibition-induced apoptosis.\",\n      \"method\": \"MazF toxin-induced translation inhibition, BIK/BAK-deficient cells, immunoprecipitation to assess MCL-1/BAK and BCL-XL/BAK complexes, genetic rescue experiments\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with mechanistic dissection of BIK-MCL-1/BCL-XL-BAK pathway\",\n      \"pmids\": [\"17403773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRP78/BiP physically interacts with BIK at the ER; GRP78 overexpression inhibits estrogen starvation-induced BAX activation and apoptosis; GRP78 knockdown sensitizes cells to estrogen starvation-induced apoptosis in a BIK-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, GRP78 overexpression and siRNA knockdown, BAX activation assays, apoptosis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional validation using siRNA, multiple apoptotic readouts\",\n      \"pmids\": [\"17440086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MCL-1 binding to BAK persists after BIK expression and prevents BIK-induced apoptosis in BAX-deficient cells; PUMA (but not BIK) can disrupt MCL-1-BAK interaction; targeted knockdown of MCL-1 allows BAK activation by BIK, demonstrating that BIK's BAX-dependency is due to MCL-1 inhibiting BAK.\",\n      \"method\": \"Immunoprecipitation, MCL-1 siRNA knockdown, BAX-deficient cell lines, apoptosis assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection via co-IP and siRNA in isogenic cell lines\",\n      \"pmids\": [\"18025305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RHBDD1, a rhomboid serine protease, cleaves BIK at a site in its transmembrane region; residues Gly142 and Ser144 of RHBDD1 are critical for this cleavage; RHBDD1 overexpression reduces BIK-mediated apoptosis while knockdown enhances it.\",\n      \"method\": \"Mutagenesis of RHBDD1 active site, overexpression/knockdown experiments, apoptosis assays\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional validation, single lab study\",\n      \"pmids\": [\"18953687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BIK interacts with phospho-ERK1/2 and suppresses nuclear translocation of activated ERK1/2; this is dependent on a functional BH3 domain (BikL61G mutant does not interact or suppress nuclear pERK1/2); BIK-mediated suppression of nuclear pERK1/2 is required for IFNγ-induced cell death in airway epithelial cells.\",\n      \"method\": \"Co-immunoprecipitation, BH3 domain point mutant (L61G), nuclear/cytosolic fractionation, bik-/- mouse AECs, phospho-ERK inhibition, apoptosis assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP, loss-of-function (bik-/- cells), and mutagenesis with defined functional consequence\",\n      \"pmids\": [\"18981230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TGF-β directly induces BIK transcription via Smad transcription factor complexes binding to a consensus Smad-binding element in the BIK promoter; TGF-β also represses BCL-XL; both effects cooperate to activate the intrinsic apoptotic pathway in B cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter-reporter assays, Smad-binding element identification, shRNA knockdown of BIK, BCL-XL overexpression\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct Smad binding to BIK promoter, combined with functional shRNA rescue experiments\",\n      \"pmids\": [\"19136942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRP78 interacts with BIK independently of the BH3 domain (unlike all other BIK protein interactions); GRP78 and BCL-2 form independent complexes with BIK; increased GRP78 expression decreases BIK binding to BCL-2, releasing BCL-2 from sequestration to suppress apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, BH3 domain mutants, GRP78 overexpression, isolated clonal cell lines, apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic co-IP with domain mapping and functional validation\",\n      \"pmids\": [\"21622563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BIK mRNA 3' end processing and expression are controlled by the poly(A) polymerase Star-PAP downstream of DNA damage; nuclear PKCδ associates with the Star-PAP complex and is required for Star-PAP-dependent BIK expression; PIPKIα binds PKCδ and is essential for PKCδ interaction with Star-PAP, with PKCδ activity stimulated by PI4,5P2.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation, mRNA 3' end processing assays, kinase activity assays, BIK mRNA 3' UTR analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, functional siRNA, biochemical assays) establishing a nuclear signaling complex controlling BIK expression\",\n      \"pmids\": [\"22244330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Src kinase-dependent resistance to apoptosis operates via Ras-Raf-Mek1/2-Erk1/2 pathway phosphorylation of BIK on Thr124, which drives BIK ubiquitylation on Lys33 and subsequent proteasomal degradation.\",\n      \"method\": \"v-Src transformed fibroblasts, Erk1/2 pathway inhibitors, phosphorylation site mutagenesis (Thr124), ubiquitylation assays, proteasome inhibition, apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of phosphorylation and ubiquitylation sites with biochemical validation of the degradation mechanism\",\n      \"pmids\": [\"22388352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SQSTM1/p62 knockdown causes cargo loading failure in autophagy, leading to accumulation of NBK/Bik on ER membranes (by blocking autophagic loading and degradation of NBK/Bik), which triggers apoptosis; NBK/Bik knockdown markedly attenuates this apoptosis in vitro and in vivo.\",\n      \"method\": \"shRNA targeting SQSTM1/p62 and NBK/Bik, autophagy flux assays, ER membrane fractionation, xenograft tumor model, apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway placement with genetic knockdown and in vivo validation, single lab\",\n      \"pmids\": [\"25002530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BIK dissociates the BAK/BCL-2 complex to enrich ER-associated BAK; BIK interacts with the kinase domain of DAPk1 to form a BIK-DAPk1-ERK1/2-BAK complex; BIK disrupts BCL-2/IP3R interaction to cause ER Ca2+ release; ER-associated BAK interacts with DAPk1 to increase ER-mitochondria contact sites facilitating mitochondrial Ca2+ uptake; the BIK BH3 helix is sufficient for ER-BAK enrichment and ER Ca2+ release but not for mitochondrial Ca2+ uptake (requires Bak).\",\n      \"method\": \"Co-immunoprecipitation, BAK knockdown, IP3R interaction assays, ER-mitochondria contact site imaging, BIK BH3 peptide experiments, Ca2+ flux assays, allergen/cigarette smoke mouse models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical and cell biological methods with in vivo validation, strong mechanistic detail\",\n      \"pmids\": [\"28986568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p53-mediated suppression of BiP expression during prolonged ER stress releases pro-apoptotic BIK from BiP, activating apoptosis; p53 suppresses bip mRNA translation by binding to the first 346-nt of bip mRNA via a p53 trans-suppression domain in the first 7 N-terminal amino acids of p53ΔN40.\",\n      \"method\": \"RNA-protein binding assays, siRNA knockdown of BiP and BIK, co-immunoprecipitation, p53 isoform expression, ER stress induction, apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of mRNA-protein binding and apoptotic release with multiple functional validations\",\n      \"pmids\": [\"28622297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The E3 ubiquitin ligase Cul5-ASB11 targets BIK for ubiquitination and degradation; ER stress activates ASB11 via the IRE1α-XBP1s axis during the adaptive UPR, stimulating BIK ubiquitination, interaction with p97/VCP, and proteolysis; genotoxic stress down-regulates this axis, stabilizing BIK to promote apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, IRE1α inhibitor, XBP1s overexpression/knockdown, ASB11 knockdown, p97/VCP interaction assays, apoptosis assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — E3 ligase identification with mechanistic pathway dissection through multiple orthogonal methods\",\n      \"pmids\": [\"31387940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Casein kinase IIα (CKIIα) phosphorylates and activates BIK to kill cells specifically in S/G2/M phase of the cell cycle; CKIIα is expressed only during G2/M phase; BIK phosphorylation at Thr33/Ser35 is required for activity even in quiescent cells; BIK localizes to and is only detected in green-fluorescent (S/G2/M) cells as shown by fluorescent cell cycle indicators.\",\n      \"method\": \"Fluorescent ubiquitin cell cycle indicators (FUCCI), co-immunoprecipitation, proteomics, BIK phosphorylation mutants, transgenic mouse airway epithelial cells, allergen exposure model\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP/proteomics identifying kinase, combined with FUCCI cell cycle tracking and mutagenesis\",\n      \"pmids\": [\"34741311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BIK is detected at both ER and mitochondria-associated ER membranes (MAMs); BIK binds directly to mitochondria-localized BCL-XL and BCL-2 in a BH3-domain-dependent manner as shown by FLIM-FRET microscopy; BIK or its binding partners relocalize at ER-mitochondria contact sites to initiate mitochondrial outer membrane permeabilization.\",\n      \"method\": \"FLIM-FRET microscopy, chimeric mitochondria-localized BCL-XL/BCL-2 mutants, BAX/BAK double-knockout BMK cells, BH3-domain mutants, co-localization in MCF-7 and BMK cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural interaction measured by FLIM-FRET with chimeric protein controls and genetic validation\",\n      \"pmids\": [\"36603764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BIK interacts with the BH4 domain of BCL-2 and with proteasome subunits RPN1 and RPN2 to enhance proteasomal degradation of nuclear proteins, suppressing NF-κB nuclear p65; BIK deficiency increases nuclear p65 and causes low-grade inflammation and spontaneous emphysema in female mice.\",\n      \"method\": \"Co-immunoprecipitation, proteasomal degradation assays, transgenic BIK airway expression, bik-/- mice, nuclear fractionation, NF-κB p65 quantification\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP identifying novel BCL-2/RPN1/RPN2 interaction with in vivo genetic validation in knockout mice\",\n      \"pmids\": [\"38113109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TMEM215 forms a complex with BiP and facilitates BiP interaction with BIK; TMEM215 knockdown triggers BIK-dependent apoptosis associated with increased mitochondria-associated ER membrane contacts and mitochondrial calcium influx; blocking IP3R or MCU abrogates TMEM215 knockdown-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation-mass spectrometry, BIK siRNA rescue, IP3R/MCU inhibitors, mitochondria-associated ER membrane imaging, EC-specific conditional knockout mice, tumor models\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — IP-MS identification of TMEM215-BiP-BIK complex with in vivo genetic validation and mechanistic calcium pathway dissection\",\n      \"pmids\": [\"37750320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BIK promotes caspase-dependent cleavage of influenza A virus nucleoprotein and M2 proteins, facilitating cytoplasmic export of viral ribonucleoprotein; bik-/- mouse airway epithelial cells show reduced viral titers, caspase 3 activation, and viral RNA export compared to wild-type cells.\",\n      \"method\": \"bik-/- mouse airway epithelial cells, caspase inhibition, viral protein cleavage assays, viral RNP export assays, in vivo infection model\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with multiple mechanistic readouts (caspase activation, viral protein cleavage, RNP export) in vitro and in vivo\",\n      \"pmids\": [\"26437021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HCV NS5B RNA-dependent RNA polymerase induces BIK expression; BIK co-localizes and co-immunoprecipitates with NS5B, suggesting BIK interacts with the HCV replication complex; BIK depletion significantly suppresses viral RNA replication and release.\",\n      \"method\": \"PCR array, co-immunoprecipitation, immunofluorescence co-localization, BIK siRNA knockdown, viral replication assays\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP/co-localization with functional siRNA validation, single lab\",\n      \"pmids\": [\"25463603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TMEM74, a lysosome transmembrane protein, co-localizes with BIK in subcellular organelles and associates with BIK via the TM domains of TMEM74 and the BH3 domain of BIK; TMEM74 inhibits BIK-induced apoptosis through this direct interaction.\",\n      \"method\": \"Co-immunoprecipitation, fluorescent co-localization, domain mapping with TM-deficient mutants, BIK apoptosis assays with TMEM74 knockdown/overexpression\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP with domain mapping and functional rescue, single lab\",\n      \"pmids\": [\"28412412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Concomitant loss of both Bik and Bim (but not either alone) arrests spermatogenesis in mice, resulting in infertility and testicular cellularity reduction similar to Bax deficiency; Bik and Bim act upstream of Bax to eliminate supernumerary germ cells during the first wave of spermatogenesis.\",\n      \"method\": \"Bik/Bim double-knockout mice, histological and cell count analyses, genetic epistasis with Bax-deficient mice\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-knockout genetic epistasis with defined in vivo phenotype and pathway placement upstream of Bax\",\n      \"pmids\": [\"16270031\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BIK is a BH3-only pro-apoptotic protein constitutively localized to the endoplasmic reticulum (ER) membrane via its C-terminal transmembrane domain, where it initiates mitochondrial apoptosis by: (1) binding and neutralizing anti-apoptotic BCL-2, BCL-XL, and MCL-1 via its BH3 domain; (2) disrupting BCL-2/IP3R interactions to release ER Ca2+ stores, which—together with DAPk1 and ER-enriched BAK—facilitates mitochondrial Ca2+ uptake at MAM contact sites; (3) promoting DRP1-dependent mitochondrial cristae remodeling; and (4) cooperating with BAK/BAX to release cytochrome c; its pro-apoptotic activity is activated by casein kinase II-mediated phosphorylation at Thr33/Ser35, is suppressed by ERK1/2-dependent phosphorylation of Thr124 driving Cul5-ASB11/ubiquitin-proteasomal degradation, and is regulated at the mRNA level by p53, E2F, Smad, and nuclear PI4,5P2/PKCδ/Star-PAP signaling; additionally, BIK interacts with proteasome subunits RPN1/RPN2 via the BCL-2 BH4 domain to enhance proteasomal degradation of nuclear proteins (including NF-κB p65), revealing a non-apoptotic function in suppressing inflammation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BIK is a BH3-only pro-apoptotic member of the BCL-2 family that functions as a sentinel at the endoplasmic reticulum to initiate the intrinsic mitochondrial apoptotic pathway. Anchored to the ER membrane via its C-terminal transmembrane domain with its bulk facing the cytosol, BIK uses its BH3 domain to bind and neutralize anti-apoptotic BCL-2, BCL-XL, and MCL-1, thereby liberating BAK and enabling BAX activation; it also disrupts BCL-2/IP3R complexes to trigger ER Ca²⁺ release, promotes DRP1-dependent mitochondrial cristae remodeling, and facilitates mitochondrial Ca²⁺ uptake at ER–mitochondria contact sites through a DAPk1-dependent mechanism [PMID:7478623, PMID:11884414, PMID:15791210, PMID:28986568, PMID:36603764]. BIK is activated by casein kinase IIα phosphorylation at Thr33/Ser35 during S/G2/M phase, transcriptionally induced by p53, Smad, and Star-PAP/PKCδ signaling, sequestered by ER chaperone GRP78/BiP, and targeted for proteasomal degradation via ERK1/2-mediated Thr124 phosphorylation and the Cul5-ASB11 E3 ligase under the IRE1α-XBP1s adaptive UPR [PMID:11084041, PMID:34741311, PMID:22388352, PMID:31387940, PMID:17440086, PMID:19136942]. Beyond apoptosis, BIK interacts with proteasome subunits RPN1/RPN2 via the BCL-2 BH4 domain to enhance nuclear proteasomal degradation of NF-κB p65, suppressing inflammation; accordingly, Bik-deficient female mice develop spontaneous emphysema with low-grade inflammation [PMID:38113109].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of BIK as a BH3-domain-containing pro-apoptotic protein that physically engages anti-apoptotic BCL-2 family members established it as a death-promoting antagonist of survival proteins.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, and apoptosis assays in transfected cells\",\n      \"pmids\": [\"7478623\", \"8816500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of death induction beyond heterodimerization was unknown\", \"Subcellular site of action unresolved\", \"Endogenous regulation of BIK expression and turnover not addressed\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Mapping the BH3 domain as necessary for BCL-2/BCL-XL binding but insufficient for apoptosis revealed that a C-terminal region (beyond residue 120) provides an additional required function, later shown to be the ER-targeting transmembrane anchor.\",\n      \"evidence\": \"Deletion mutagenesis with yeast two-hybrid and functional apoptosis assays\",\n      \"pmids\": [\"9305912\", \"9082997\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nature of the C-terminal contribution (membrane anchor vs. protein interaction) was unresolved\", \"Downstream effectors were not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that phosphorylation at Thr33/Ser35 by a casein kinase II-related enzyme activates BIK's pro-apoptotic function established the first post-translational activation mechanism for BIK.\",\n      \"evidence\": \"Phosphorylation mapping, site-directed mutagenesis, partial kinase purification from HeLa extracts\",\n      \"pmids\": [\"11084041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase was only partial (CKII-related)\", \"Cell-cycle context of phosphorylation was unknown\", \"Relationship between phosphorylation and BCL-2 binding was unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localization of BIK to the ER membrane—with retention of full apoptotic activity when ER-restricted—fundamentally redefined BIK as an ER-resident initiator of mitochondrial apoptosis, distinct from mitochondria-localized BH3-only proteins.\",\n      \"evidence\": \"Subcellular fractionation, chimeric ER-anchor constructs, in vitro reconstitution with ER and cytosol, p53-induction studies\",\n      \"pmids\": [\"11884414\", \"11971188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal transmitted from ER to mitochondria was unidentified\", \"Whether Ca²⁺ was involved was unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that BIK-induced apoptosis is entirely BAX-dependent—even in BAK-expressing cells—positioned BIK as an indirect activator that de-represses effector proteins rather than directly permeabilizing membranes.\",\n      \"evidence\": \"Conditional adenoviral BIK expression in BAX-deficient cells with BAX re-expression rescue\",\n      \"pmids\": [\"12853473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BIK signals to BAX from the ER was mechanistically undefined\", \"Role of BAK at the ER was not yet explored\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Multiple studies converged to show that ER-localized BIK triggers Ca²⁺ release from ER stores, recruits DRP1 for mitochondrial cristae remodeling, and cooperates with BAX/BAK for cytochrome c release—establishing the ER-to-mitochondria Ca²⁺ signaling axis as the core BIK mechanism; in parallel, Bik/Bim double-knockout mice revealed a physiological role in spermatogenesis upstream of Bax.\",\n      \"evidence\": \"Live imaging, DRP1 dominant-negative/siRNA, Ca²⁺ assays, BAX/BAK DKO cells, Bik/Bim DKO mice with histology\",\n      \"pmids\": [\"15791210\", \"15809295\", \"15767553\", \"16270031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the ER Ca²⁺ channel involved was not determined\", \"Precise mechanism of DRP1 recruitment was unclear\", \"Whether BIK directly engages BAK at the ER was unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"BIK was shown to displace BAK from MCL-1/BCL-XL sequestration, while GRP78/BiP was identified as an ER-resident inhibitor that sequesters BIK independently of the BH3 domain—revealing dual layers of BIK regulation at the ER.\",\n      \"evidence\": \"Co-immunoprecipitation of MCL-1/BAK complexes after BIK expression; GRP78 overexpression/siRNA with apoptosis readouts; BH3-mutant mapping\",\n      \"pmids\": [\"17403773\", \"17440086\", \"18025305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BIK's inability to displace MCL-1 from BAK (unlike PUMA) left the MCL-1 neutralization mechanism incomplete\", \"GRP78 binding site on BIK was unmapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"BIK was found to interact with phospho-ERK1/2 via its BH3 domain and suppress ERK nuclear translocation, revealing a non-canonical signaling function; separately, RHBDD1 rhomboid protease was identified as cleaving BIK in its transmembrane domain to attenuate apoptosis.\",\n      \"evidence\": \"Co-IP with BH3 mutant control and bik−/− cells for ERK; RHBDD1 active-site mutagenesis with apoptosis assays\",\n      \"pmids\": [\"18981230\", \"18953687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts for RHBDD1-mediated BIK cleavage were not defined\", \"Whether ERK sequestration and apoptosis induction are separable functions was unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of direct Smad-binding elements in the BIK promoter established TGF-β as a transcriptional inducer of BIK, adding to the p53/E2F axis and explaining BIK's role in TGF-β-induced B-cell apoptosis.\",\n      \"evidence\": \"ChIP showing Smad binding to BIK promoter, promoter-reporter assays, BIK shRNA rescue\",\n      \"pmids\": [\"19136942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other Smad family members differentially regulate BIK was not tested\", \"Integration of multiple transcriptional inputs was not modeled\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two degradation-regulation mechanisms were defined: ERK1/2-mediated Thr124 phosphorylation drives Lys33 ubiquitylation and proteasomal degradation of BIK (explaining Src/Ras oncogene resistance), while Star-PAP/PKCδ/PI4,5P2 nuclear signaling controls BIK mRNA 3′ end processing after DNA damage.\",\n      \"evidence\": \"Phosphosite mutagenesis with ubiquitylation assays in v-Src-transformed cells; siRNA/co-IP of Star-PAP complex with mRNA processing assays\",\n      \"pmids\": [\"22388352\", \"22244330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ligase mediating Thr124-dependent ubiquitylation was not identified in this study\", \"Whether Star-PAP regulation extends to other BH3-only genes was unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"BIK was shown to form a complex with DAPk1, ERK1/2, and BAK at the ER, disrupt BCL-2/IP3R interactions to release ER Ca²⁺, and increase ER–mitochondria contact sites for mitochondrial Ca²⁺ uptake—providing a complete mechanistic pathway from ER perturbation to mitochondrial engagement.\",\n      \"evidence\": \"Co-IP, IP3R interaction assays, ER–mitochondria contact imaging, BH3 peptide experiments, Ca²⁺ flux measurements, in vivo allergen/smoke models\",\n      \"pmids\": [\"28986568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of BIK–DAPk1 interaction was not resolved\", \"Stoichiometry and dynamics of the quaternary complex were undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of Cul5-ASB11 as the E3 ligase targeting BIK, activated by the IRE1α-XBP1s adaptive UPR and involving p97/VCP extraction, explained how ER stress initially suppresses BIK to allow adaptation, while genotoxic stress downregulates this axis to stabilize BIK.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, IRE1α inhibitor, XBP1s and ASB11 knockdown, p97/VCP interaction assays\",\n      \"pmids\": [\"31387940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Cul5-ASB11 also mediates the ERK-Thr124-dependent degradation was not tested\", \"Recognition determinants on BIK for ASB11 binding were unmapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CKIIα was confirmed as the activating kinase for BIK, and its expression restricted to G2/M phase explained why BIK kills specifically dividing (S/G2/M) cells—linking BIK activation to cell-cycle progression.\",\n      \"evidence\": \"FUCCI cell-cycle tracking, co-IP/proteomics identifying CKIIα, phosphomutant BIK in transgenic mouse airway epithelial cells\",\n      \"pmids\": [\"34741311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CKIIα phosphorylation creates a binding interface for downstream effectors was unknown\", \"Cell-type generality beyond airway epithelia was not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Three major advances: FLIM-FRET confirmed direct BIK interaction with mitochondria-localized BCL-XL/BCL-2 at MAMs; TMEM215-BiP was identified as a ternary complex restraining BIK; and BIK's interaction with RPN1/RPN2 proteasome subunits via BCL-2 BH4 domain was shown to promote nuclear proteasomal degradation of NF-κB p65, revealing a non-apoptotic anti-inflammatory function (Bik−/− female mice develop spontaneous emphysema).\",\n      \"evidence\": \"FLIM-FRET with chimeric constructs; IP-MS for TMEM215-BiP-BIK; co-IP/proteasome assays and bik−/− mice with lung pathology\",\n      \"pmids\": [\"36603764\", \"37750320\", \"38113109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for BIK–RPN1/RPN2 interaction is unresolved\", \"Sex-specific mechanism of emphysema in Bik−/− mice is unexplained\", \"Whether BIK's proteasomal function operates in tissues beyond lung is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis of BIK's multivalent interactions at ER–mitochondria contact sites, how its apoptotic and non-apoptotic (proteasomal/anti-inflammatory) functions are partitioned in different cell types, and whether BIK loss contributes to human disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of BIK in complex with any partner\", \"Human genetic disease associations via causative mutations are absent\", \"Relative contributions of CKIIα activation vs. Cul5-ASB11 degradation in setting BIK protein levels in vivo are unquantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 7, 11, 13, 15, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 6, 20, 21, 25, 27]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 5, 7, 8, 9, 10, 11, 13, 21, 25]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [22, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [15, 16, 19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BCL2\",\n      \"BCL2L1\",\n      \"MCL1\",\n      \"BAK1\",\n      \"HSPA5\",\n      \"DAPK1\",\n      \"PSMD1\",\n      \"ASB11\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}